189 related articles for article (PubMed ID: 37977064)
1. Biological effects of IL-21 on immune cells and its potential for cancer treatment.
Ma M; Xie Y; Liu J; Wu L; Liu Y; Qin X
Int Immunopharmacol; 2024 Jan; 126():111154. PubMed ID: 37977064
[TBL] [Abstract][Full Text] [Related]
2. IL-21: a pleiotropic cytokine with potential applications in oncology.
Croce M; Rigo V; Ferrini S
J Immunol Res; 2015; 2015():696578. PubMed ID: 25961061
[TBL] [Abstract][Full Text] [Related]
3. Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy.
Mortara L; Balza E; Bruno A; Poggi A; Orecchia P; Carnemolla B
Front Immunol; 2018; 9():2905. PubMed ID: 30619269
[TBL] [Abstract][Full Text] [Related]
4. Role of IL-21 in immune-regulation and tumor immunotherapy.
di Carlo E; de Totero D; Piazza T; Fabbi M; Ferrini S
Cancer Immunol Immunother; 2007 Sep; 56(9):1323-34. PubMed ID: 17447063
[TBL] [Abstract][Full Text] [Related]
5. IL-35: New Target for Immunotherapy Targeting the Tumor Microenvironment.
Yi P; Yu W; Xiong Y; Dong Y; Huang Q; Lin Y; Du Y; Hua F
Mol Cancer Ther; 2024 Feb; 23(2):148-158. PubMed ID: 37988561
[TBL] [Abstract][Full Text] [Related]
6. The IL-2 cytokine family in cancer immunotherapy.
Sim GC; Radvanyi L
Cytokine Growth Factor Rev; 2014 Aug; 25(4):377-90. PubMed ID: 25200249
[TBL] [Abstract][Full Text] [Related]
7. IL-27, a pleiotropic cytokine for fine-tuning the immune response in cancer.
Beizavi Z; Zohouri M; Asadipour M; Ghaderi A
Int Rev Immunol; 2021; 40(5):319-329. PubMed ID: 33146571
[TBL] [Abstract][Full Text] [Related]
8. Biological effects of IL-15 on immune cells and its potential for the treatment of cancer.
Zhang S; Zhao J; Bai X; Handley M; Shan F
Int Immunopharmacol; 2021 Feb; 91():107318. PubMed ID: 33383444
[TBL] [Abstract][Full Text] [Related]
9. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-21 as an adjuvant in cancer immunotherapy: Current advances and future directions.
Li X; Wu M; Lu J; Yu J; Chen D
Biochim Biophys Acta Rev Cancer; 2024 Mar; 1879(2):189084. PubMed ID: 38354828
[TBL] [Abstract][Full Text] [Related]
11. IL-35 Regulates the Function of Immune Cells in Tumor Microenvironment.
Liu K; Huang A; Nie J; Tan J; Xing S; Qu Y; Jiang K
Front Immunol; 2021; 12():683332. PubMed ID: 34093586
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment.
Habanjar O; Bingula R; Decombat C; Diab-Assaf M; Caldefie-Chezet F; Delort L
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835413
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of interleukin-21 in cancer.
Isvoranu G; Chiritoiu-Butnaru M
Front Immunol; 2024; 15():1369743. PubMed ID: 38638431
[TBL] [Abstract][Full Text] [Related]
14. Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy.
Mortezaee K; Majidpoor J
Cell Oncol (Dordr); 2022 Jun; 45(3):333-353. PubMed ID: 35587857
[TBL] [Abstract][Full Text] [Related]
15. IL-21 Signaling in the Tumor Microenvironment.
Chabab G; Bonnefoy N; Lafont V
Adv Exp Med Biol; 2020; 1240():73-82. PubMed ID: 32060889
[TBL] [Abstract][Full Text] [Related]
16. Interleukine-10 in ovarian cancer.
Levin G; Gotlieb WH
Chin Clin Oncol; 2024 May; ():. PubMed ID: 38735685
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancer.
Zeh HJ; Hurd S; Storkus WJ; Lotze MT
J Immunother Emphasis Tumor Immunol; 1993 Aug; 14(2):155-61. PubMed ID: 7904180
[TBL] [Abstract][Full Text] [Related]
18. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation.
Chen L; Chen H; Ye J; Ge Y; Wang H; Dai E; Ren J; Liu W; Ma C; Ju S; Guo ZS; Liu Z; Bartlett DL
Theranostics; 2021; 11(14):6668-6681. PubMed ID: 34093846
[No Abstract] [Full Text] [Related]
20. The role of IL-33/ST2 signaling in the tumor microenvironment and Treg immunotherapy.
Lei S; Jin J; Zhao X; Zhou L; Qi G; Yang J
Exp Biol Med (Maywood); 2022 Oct; 247(20):1810-1818. PubMed ID: 35733343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
